Publications & Works

Publication Network
Articles 104
All (104)
SCI-E, SSCI, AHCI (77)
SCI-E, SSCI, AHCI, ESCI (85)
ESCI (8)
Scopus (86)
TRDizin (26)
Other Publications (5)

1. Between diffuse and limited: the unique identity of systemic sclerosis–overlap syndromes

KÜÇÜK H., VASİ İ., KARADUMAN İ., ERDEN A.
Anatolian Current Medical Journal , vol.7, no.6, pp.913-918, 2025 (Peer-Reviewed Journal)

2. A new characteristıc of systemic lupus erythematosus: subclinical vein involvement-an in-depth biochemical and imaging study.

Yildirim D., Erden A., Ibrahimkhanli N., Elefante E., Duran R., Kanik H. K., et al.
Rheumatology (Oxford, England) , 2025 (SCI-Expanded) identifier

3. Vascular calcification in Takayasu arteritis: relationship with metabolic syndrome, left ventricular mass index, and intima-media thickness.

Karadeniz H., Kesen S., Akhan M. B., Unlu S., Kardas R. C., Guler A. A., et al.
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese , vol.85, pp.70-80, 2025 (SCI-Expanded) identifier identifier

4. Evolution of Clinical Characteristics and Treatment Strategies in Turkish SLE Patients Over Two Decades: A Retrospective Cohort Study

Kanik H. K., ERDEN A., Yildirim D., Kanik A. B., DURAN R., Kardas R. C., et al.
BRATISLAVA MEDICAL JOURNAL , vol.126, no.9, pp.2329-2336, 2025 (SCI-Expanded, Scopus) Sustainable Development identifier identifier

5. Importance of potential prothrombotic state markers in Behçet's disease and correlation with vascular ultrasound.

Karadeniz H., Mammadov T., Cerit M. N., Kardas R. C., Guler A. A., Yıldırım D., et al.
Irish journal of medical science , vol.194, no.4, pp.1525-1532, 2025 (SCI-Expanded) identifier identifier identifier

6. Is Myopenia or Myosteatosis Clinically Relevant in Systemic Sclerosis? Skeletal Muscle Assessment Using Computed Tomography.

Kılıç A. C., Vasi İ., Kılıç H. K., Erden A., Gündoğdu O., Kardaş R. C., et al.
Academic radiology , vol.32, no.6, pp.3574-3584, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

7. Is IgG4-Related Disease a Potential Risk Factor for Multiple Malignancies?

Duran R., Yıldırım D., Kardaş R. C., Vasi İ., Küçük H., Erden A.
International journal of rheumatic diseases , vol.28, no.5, 2025 (SCI-Expanded) identifier

8. PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD.

Alp G. T., Vasi İ., Alp E., Güler A. A., Karadeniz H., Gülbahar Ö., et al.
Biomarkers in medicine , pp.1-7, 2025 (SCI-Expanded) identifier

9. Lupus and IgA nephropathy: coexistence or coincident?

Duran R., Yıldırım D., Can Kardaş R., Vasi İ., Kaya B., Çakır Y., et al.
Wiener klinische Wochenschrift , 2025 (SCI-Expanded) identifier

10. Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry

Sota J., Ragab G., AlMaglouth I., Lopalco G., Tufan A., Direskeneli H., et al.
Joint Bone Spine , vol.92, no.2, 2025 (SCI-Expanded) identifier identifier

11. Serum CXCL-13 levels are associated with active neurological involvement in patients with systemic lupus erythematosus.

Yildirim D., Erden A., Fanouriakis A., Koc Kanik H., Babaoglu H., Kardas R. C., et al.
Lupus , 2025 (SCI-Expanded) identifier

12. Frequency of severe infections in rheumatic disease patients receiving bDMARDs post-kidney transplantation: a multicenter study

Yıldırım T. D., Kökoğlu E. O., COŞKUN B. N., YILDIRIM D., Basaran E., ŞENEL A. S., et al.
Clinical Rheumatology , vol.44, no.2, pp.831-838, 2025 (SCI-Expanded) identifier identifier

13. Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry.

Ruscitti P., Di Cola I., Vitale A., Caggiano V., Palumbo P., Di Cesare E., et al.
The Journal of rheumatology , 2025 (SCI-Expanded) identifier

14. Intersecting Pathways: Moyamoya Syndrome and Antiphospholipid Antibodies—A Comprehensive Review of Clinical Insights, Therapeutic Considerations and Prospective Perspectives

VASİ İ., KARDAŞ R. C., TALAY K., YILDIRIM D., KAYA B., DURAN R., et al.
Acta Neurologica Scandinavica , vol.2025, no.1, 2025 (SCI-Expanded) identifier

15. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders

Sota J., Guerriero S., Lopalco G., TUFAN A., Ragab G., Almaglouth I., et al.
OCULAR IMMUNOLOGY AND INFLAMMATION , vol.33, no.1, pp.48-55, 2025 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

16. Evaluation of treatment compliance in gout patients: a patient-centered study

Görgülü M. B., KARDAŞ R. C., Koç Şeramet D., Mercan R., Tezcan M. E., TUFAN A., et al.
Turkish Journal of Medical Sciences , vol.55, no.2, pp.413-422, 2025 (SCI-Expanded) identifier identifier

17. Possible Association between Behçet’s Disease and Periodontal diseases

Orduyilmaz F., Özmeriç Kurtuluş N., Elgün Ülkar S., Gürbüz S., Küçük H., Bitik B., et al.
BMC Oral Health , vol.24, no.1, 2024 (SCI-Expanded) identifier identifier identifier

18. Calcineurin inhibitors in unplanned pregnancies with active lupus disease: A retrospective observational study.

Vasi İ., Yıldırım D., Kardaş R. C., Kaya B., Duran R., Alp G. T., et al.
International journal of clinical pharmacology and therapeutics , vol.62, no.7, pp.326-333, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

19. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS).

Bilgin E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and emergency medicine , vol.19, no.4, pp.1025-1034, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

20. Performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for antineutrophil cytoplasmic antibody-associated vasculitis in previously diagnosed adult patients from Türkiye

Yilmaz S., KÜÇÜK H., Ozgunen M. S., KARDAŞ R. C., Tecer D., VASİ İ., et al.
ARCHIVES OF RHEUMATOLOGY , vol.39, no.2, pp.194-202, 2024 (SCI-Expanded) Sustainable Development identifier identifier identifier

21. Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria.

Vasi İ., Kardaş R. C., Ekici M., Yıldırım D., Kaya B., Duran R., et al.
International journal of rheumatic diseases , vol.27, no.5, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

22. Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression.

Güven S. C., Erden A., Küçük H., Apaydın H., Polat B., Kardaş R. C., et al.
European journal of rheumatology , vol.11, no.1, pp.2-7, 2024 (ESCI) identifier identifier identifier

23. HEPATOSTEATOZ DEĞERLENDİRMEDE ETKİN BİR ÖLÇEĞİN PSÖRİATİK ARTRİTLİ HASTALARDA KULLANIMI: DOKU ATENUASYON GÖRÜNTÜLEME

Yıldırım D., Tamer A., Cerit M. N., Küçük H., Şendur H. N.
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi , vol.26, no.2, pp.136-141, 2024 (Peer-Reviewed Journal) Creative Commons License

24. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.

Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.
Clinical and experimental rheumatology , vol.42, no.4, pp.816-821, 2024 (SCI-Expanded) identifier identifier

25. Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.

Yildirim D., Kardas R. C., Gun M., Kaya B., Vasi I., Duran R., et al.
International immunopharmacology , vol.128, pp.111491, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

26. Is compressed colchicine tablet superior to other colchicine preparations in patients with familial Mediterranean fever?

Vasi İ., Kardaş R. C., Yıldırım D., Kaya B., Duran R., Karadeniz H., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , vol.62, pp.77-82, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

27. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries

Vitale A., Caggiano V., TUFAN A., Ragab G., BATU AKAL E. D., Portincasa P., et al.
FRONTIERS IN IMMUNOLOGY , vol.15, 2024 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

28. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.

AVANOĞLU GÜLER A., ÖZÇİMEN B., Aydoğdu M. S., Sari A., Numune A., TÜZÜN ERSAN N., et al.
Turkish journal of medical sciences , vol.54, no.1, pp.76-85, 2023 (SCI-Expanded) Creative Commons License identifier identifier

29. Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry

Vitale A., Caggiano V., Lopalco G., Mayrink Giardini H. A., Ciccia F., Almaghlouth I. A., et al.
RMD Open , vol.9, no.4, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

30. The predictors of paradoxical reactions especially psoriasis with biologic therapy from the TReasure database: a 5-year follow-up study.

Yagiz B., Lermi N., Coskun B. N., Dalkilic E., Kiraz S., Erden A., et al.
Rheumatology (Oxford, England) , vol.62, pp.3962-3967, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

31. Could serum HMGB1 levels be a predictor associated with psoriatic arthritis?

Yildirim D., Baykul M., Edek Y. C., Gulengul M., Alp G. T., Eroglu F. S., et al.
BIOMARKERS IN MEDICINE , vol.17, no.20, pp.871-880, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

32. What is isolated / idiopathic / non-syndromic aortitis? What is not?

KARADENİZ H., KÜÇÜK H.
Acta Medica , vol.54, 2023 (Peer-Reviewed Journal)

33. Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study.

Karadeniz H., Ucar M., Mammadov T., Mirzayeva L. S., Guler A. A., Kardas R. C., et al.
Seminars in arthritis and rheumatism , vol.62, pp.152246, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

34. Effects of interleukin-1 antagonists on de novo and pre-existing damage in patients with familial Mediterranean fever

YILDIRIM D., Ozkiziltas B., VASİ İ., Karadeniz H., Guler A. A., KARDAŞ R. C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.41, no.10, pp.2056-2061, 2023 (SCI-Expanded) identifier

35. Sonoelastography and S100 proteins in the differential diagnosis of IgG4-related disease (IgG4-RD)

Karadeniz H., Yılmaz Demirci N., Cerit M. N., Allahverdiyeva S., Paşaoğlu H., Karaoğlan A., et al.
Ulusal Romatoloji Dergisi , vol.15, no.2, pp.73-81, 2023 (Scopus) Creative Commons License identifier

36. Serum triggering receptor expressed on myeloid cells-1 (TREM-1) levels may be associated with disease activity in patients with familial Mediterranean fever

YILDIRIM D., avcu a., erdoğan e., ERDEN A., KÜÇÜK H.
Ulusal Romatoloji Dergisi , vol.15, no.2, pp.67-72, 2023 (Scopus) identifier

37. COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease

AVANOĞLU GÜLER A., YÜCE İNEL T., KAŞİFOĞLU T., COŞKUN C., KARADENİZ H., YILDIRIM D., et al.
MODERN RHEUMATOLOGY , vol.33, pp.786-791, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

38. Lacrimal gland ultrasonography and elastography as a diagnostic and activity tool for primary Sjogren's syndrome

KARADENİZ H., CERİT M. N., AVANOĞLU GÜLER A., BİLİCİ SALMAN R., SATIŞ H., YILDIRIM D., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.26, no.6, pp.1083-1090, 2023 (SCI-Expanded) identifier identifier identifier

39. Coexistence of 3q29 microdeletion syndrome and Takayasu arteritis: A case report

COŞKUN C., Kardaş R. C., KÜÇÜK H.
International Journal of Rheumatic Diseases , vol.26, no.4, pp.778-780, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

40. Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD

KARADENİZ H., AVANOĞLU GÜLER A., Kardaş R. C., Karadeniz M., PAŞAOĞLU H., KÜÇÜK H., et al.
Turkish Journal of Medical Sciences , vol.53, no.3, pp.666-674, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

41. Dual Biologic Therapy in Patients with Familial Mediterranean Fever and Spondyloarthritis: Case-Based Review

Yıldırım D., KARDAŞ R. C., ÖZKIZILTAŞ B., VASİ İ., KÜÇÜK H., ÖZTÜRK M. A., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.10, no.1, pp.29-33, 2023 (ESCI) Sustainable Development identifier identifier

42. Phosphate Nephropathy in a Patient with Takayasu Arteritis

BİÇER ORAL İ., KARDAŞ R. C., ÖĞÜT B., IŞIK GÖNÜL İ., KÜÇÜK H.
EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.10, 2023 (ESCI) identifier identifier

43. Effects of Inspiratory Muscle Training in Patients with post-COVID-19

Sari F., Bayram S., Pala G. G., Çömçe F., Küçük H., Oskay D.
Harran Üniversitesi Tıp Fakültesi Dergisi , vol.19, no.3, pp.581-588, 2022 (Peer-Reviewed Journal) Sustainable Development

44. Development and implementation of the AIDA International Registry for patients with Behcet's disease

Vitale A., Della Casa F., Ragab G., Almaghlouth I. A., Lopalco G., Pereira R. M., et al.
INTERNAL AND EMERGENCY MEDICINE , vol.17, no.7, pp.1977-1986, 2022 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

45. The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases

Gaggiano C., Vitale A., TUFAN A., Ragab G., Aragona E., Wiesik-Szewczyk E., et al.
FRONTIERS IN MEDICINE , vol.9, 2022 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

46. Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography

Salman R. B., Koca G., Ates S., Yapar D., Babaoglu H., Satis H., et al.
MODERN RHEUMATOLOGY , vol.32, no.5, pp.938-945, 2022 (SCI-Expanded) identifier identifier identifier

47. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis

KARADENİZ H., AVANOĞLU GÜLER A., KOCA G., BİLİCİ SALMAN R., SATIŞ H., Atas N., et al.
CLINICAL RHEUMATOLOGY , vol.41, no.4, pp.1169-1176, 2022 (SCI-Expanded) identifier identifier identifier

48. Factors influencing severe COVID-19 in systemic vasculitis patients: comment on the article by Rutherford et al

Kardas R. C., KÜÇÜK H.
ARTHRITIS & RHEUMATOLOGY , vol.74, no.4, pp.725, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

49. Factors affecting patient-acceptable symptom states and treatment decision in familial Mediterranean fever

YILDIRIM D., Vasi I., Tahta E., Kardas R. C., Ozkiziltas B., KÜÇÜK H., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.6, pp.1991-1996, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

50. ANCA-associated vasculitis with temporal artery involvement: A report of two cases

Varan Ö., Öğüt B., Küçük H., Tufan A., Dursun A., Göker B.
Ulusal Romatoloji Dergisi , vol.14, pp.29-31, 2022 (Scopus) Creative Commons License identifier identifier

51. The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients

Karadeniz H., Avanoğlu Güler A., Özger H. S., Yıldız P., Erbaş G., Bozdayı G., et al.
Biomarker Insights , vol.17, 2022 (ESCI) Sustainable Development identifier identifier identifier

52. Budd-Chiari syndrome in Behcet's disease: a retrospective multicenter study

Akyol L., Toz B., Bayindir O., Zengin O., Cansu D., Yigit M., et al.
CLINICAL RHEUMATOLOGY , vol.41, no.1, pp.177-186, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

53. Should timing be considered before abandoning convalescent plasma in covid-19? Results from the Turkish experience

Ateş İ., Erden A., Güven S. C., Gürler E. K., Çağlayan A., Güçbey Ö., et al.
Transfusion and Apheresis Science , vol.60, no.6, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development identifier identifier identifier

54. EVALUATION OF MATERNAL AND FETAL OUTCOMES OF PREGNANT WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS

TURGUT E., TURAN G., KOOHNAVARD S., KÜÇÜK H., TUFAN A., KARÇAALTINCABA D.
Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi , vol.18, no.4, pp.1056-1061, 2021 (Peer-Reviewed Journal) Sustainable Development

55. Composite endpoints for Sjögren's Syndrome

YILDIRIM D., KÜÇÜK H., TUFAN A.
The Lancet Rheumatology , vol.3, no.11, 2021 (SCI-Expanded) identifier identifier identifier

56. Composite endpoints for Sjogren's Syndrome

YILDIRIM D., KÜÇÜK H., TUFAN A.
LANCET RHEUMATOLOGY , vol.3, no.11, 2021 (SCI-Expanded) identifier identifier identifier

57. Granulomatöz Polianjiitis Tanısı Alan Hastada Eş Zamanlı Covid-19 ve Hızlı İlerleyen Glomerulonefrit Yönetimi Olgu Sunumu

BAŞ D., KÜÇÜK H.
Gazi Medical Journal , vol.32, no.4, 2021 (Scopus) Sustainable Development

58. DIAGNOSTIC ACCURACY OF SERUM MARKERS IN LARGE VESSEL VASCULITIS AND CORRELATION WITH PET IMAGING

Salman R. B., Satis H., Guler A. A., KARADENİZ H., KÜÇÜK H., HAZNEDAROĞLU Ş., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.80, pp.1077, 2021 (SCI-Expanded) Creative Commons License identifier

59. Diz Osteoartrit’inde Ultrasonografi Bulgularının Womac Osteoartrit İndeksi ve EQ-5D Genel Yaşam Kalite Ölçeği ile İlişkisi

VARAN Ö., KÜÇÜK H., BABAOĞLU H., ATAŞ N., TUFAN A.
Van Tıp Dergisi , vol.28, no.4, pp.576-580, 2021 (Peer-Reviewed Journal) identifier

60. A Case Report on Simultaneous Covid-19 and Rapidly Progressive Glomerulonephritis Management in a Patient with Granulomatosis Polyangiitis

Bas D., KÜÇÜK H.
GAZI MEDICAL JOURNAL , vol.32, no.4, pp.585-588, 2021 (ESCI) Sustainable Development identifier identifier

61. Serum defensin levels in patients with systemic sclerosis

Gedik T. E., Kucuk H., Göker B., Haznedaroğlu Ş., Paşaoğlu H., Varan O., et al.
ADVANCES IN RHEUMATOLOGY , vol.60, no.1, 2020 (SCI-Expanded) identifier identifier identifier

62. Hypercalcemia in a Patient With Granulomatosis With Polyangiitis.

Helvacı Ö., Erdogan Yon M. E., Kucuk H., Tufan A., Guz G.
American journal of kidney diseases : the official journal of the National Kidney Foundation , vol.76, no.5, 2020 (SCI-Expanded) identifier

63. Translation, validation and cross-cultural adaptation of the mouth handicap in systemic sclerosis questionnaire into the Turkish language

Tore N. G., Sari F., Tuna Z., Kucuk H., Haznedaroğlu Ş., Oskay D.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.23, pp.669-673, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

64. YÜKSEK RAKIMDA YAŞAYAN BEHÇET HASTALARINDA HEMOTOKRİT YÜKSEKLİĞİNİN VASKÜLER TUTULUMA ETKİSİ

KÜÇÜK H., KUDAŞ Ö.
Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.53, no.1, pp.25-28, 2020 (Peer-Reviewed Journal)

65. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients A Single-Center Real-Life Study

Babaoglu H., Varan O., Kucuk H., Atas N., SATIŞ H., Salman R., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.26, no.1, pp.7-13, 2020 (SCI-Expanded) identifier identifier identifier

66. Platelet/lymphocyte ratio and mean platelet volume in patients with granulomatosis with polyangiitis

Kucuk H., Tecer D., GÖKER B., Varan O., Babaoglu H., Guven S. C., et al.
ADVANCES IN RHEUMATOLOGY , vol.60, no.1, 2019 (SCI-Expanded) Sustainable Development identifier identifier identifier

67. Chronic inflammation in adult familial Mediterranean fever patients: underlying causes and association with amyloidosis

Varan O., Kucuk H., Babaoglu H., Tecer D., Atas N., Salman R. B., et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , vol.48, no.4, pp.315-319, 2019 (SCI-Expanded) identifier identifier identifier

68. The MEFV variants in patients with familial Mediterranean fever and their clinical correlations

VARAN Ö., KÜÇÜK H., BABAOĞLU H., ATAŞ N., Salman r. b., SATIŞ H., et al.
Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi , vol.52, no.2, pp.162-166, 2019 (Peer-Reviewed Journal) identifier

69. Effect of interleukin-1 antagonists on the quality of life in familial Mediterranean fever patients

Varan O., Kucuk H., Babaoglu H., Atas N., Salman R. B., SATIŞ H., et al.
CLINICAL RHEUMATOLOGY , vol.38, no.4, pp.1125-1130, 2019 (SCI-Expanded) identifier identifier identifier

70. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis

Varan O., Kucuk H., Babaoglu H., Guven S. C., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.
MODERN RHEUMATOLOGY , vol.29, no.2, pp.363-366, 2019 (SCI-Expanded) identifier identifier identifier

71. On demand use of anakinra for attacks of familial Mediterranean fever (FMF)

Babaoglu H., Varan O., Kucuk H., Atas N., SATIŞ H., Salman R., et al.
CLINICAL RHEUMATOLOGY , vol.38, no.2, pp.577-581, 2019 (SCI-Expanded) identifier identifier identifier

72. Kinesiophobia and related factors in systemic lupus erythematosus patients

Baglan Yentur S., Karatay S., OSKAY D., TUFAN A., Kucuk H., HAZNEDAROĞLU Ş.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.5, pp.1324-1331, 2019 (SCI-Expanded) identifier identifier identifier

73. The effects of early neurodevelopmental Bobath approach and mobilization on quadriceps muscle thickness in stroke patients

GÜÇLÜ GÜNDÜZ A., YAZICI G., ÖZKUL Ç., Kucuk H., BATUR ÇAĞLAYAN H. Z., NAZLIEL B.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.49, no.1, pp.318-326, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier identifier

74. Comment on: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials

Tecer D., Kucuk H.
RHEUMATOLOGY , vol.57, no.11, pp.2060, 2018 (SCI-Expanded) Creative Commons License identifier identifier

75. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients

Sonmez C., Yucel A., Yesil T. H., Kucuk H., Sezgin B., Mercan R., et al.
CLINICAL RHEUMATOLOGY , vol.37, no.10, pp.2797-2804, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

76. FMF and Sjogren’s Syndrome Overlap in an Elderly Patient: A Rare Coincidence or a Causal Association?

ŞENGÜL AYÇİÇEK G., ÇETİNER T. A., ARIK G., CANBAZ B., SÜMER F., KARA Ö., et al.
Journal of Geriatric Medicine and Gerontology , vol.4, no.2, 2018 (Peer-Reviewed Journal)

77. Acute lupus choroidopathy: multimodal imaging and differential diagnosis from central serous chorioretinopathy

Hasanreisoglu M., Ikiz G. D. G., Kucuk H., Varan O., ÖZDEK Ş.
INTERNATIONAL OPHTHALMOLOGY , vol.38, no.1, pp.369-374, 2018 (SCI-Expanded) identifier identifier identifier

78. Hand functions in systemic lupus erythematosus: a comparative study with rheumatoid arthritis patients and healthy subjects

Balan Yentur S., TUNA Z., METE O., GÖKKURT A., TORE N. G., Kucuk H., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.4, pp.840-844, 2018 (SCI-Expanded) identifier identifier identifier

79. Osteitis as a manifestation of familial Mediterranean fever

Babaoglu H., Varan O., Kucuk H., Turan A., TUFAN A.
RHEUMATOLOGY , vol.56, no.11, pp.2035-2036, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

80. Nailfold Capillaroscopy Findings Mimicking Systemic Sclerosis in a Patient With Port-Wine Stain

Guven S. C., Varan O., Kucuk H.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.23, no.7, pp.394, 2017 (SCI-Expanded) identifier identifier

81. Serum ferritin as an activity marker for granulamotosis with polyangiitis

Kucuk H., Varan O., GÖKER B., Bitik B., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.
RENAL FAILURE , vol.39, no.1, pp.566-569, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

82. American College of Rheumatology/European League Against Rheumatism Sjogren's Syndrome Classification Criteria May Not Be Adequate for Extraglandular Disease and Necessitate Defining "Seronegative Sjogren's Syndrome": Comment on the Article by Shiboski et al

Tezcan M. E., Kucuk H., GÖKER B.
ARTHRITIS & RHEUMATOLOGY , vol.69, no.6, pp.1341-1342, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

83. Osteoartrit progresyonunun kantifikasyonunda direktradyografinin avantajlar› ve dezavantajlar›

KÜÇÜK H., GÖKER B., HAZNEDAROĞLU Ş.
RAED Dergisi , vol.8, no.1, pp.1-4, 2017 (Peer-Reviewed Journal)

84. Predictive value of neutrophil/lymphocyte ratio in renal prognosis of patients with granulomatosis with polyangiitis

Kucuk H., GÖKER B., Varan O., Dumludag B., HAZNEDAROĞLU Ş., ÖZTÜRK M. A., et al.
RENAL FAILURE , vol.39, no.1, pp.273-276, 2017 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

85. Serum Vitamin B12, Homocysteine and Methylmalonic Acid Levels in Patients With Parenchymal Neuro-Behcet's Syndrome

Bitik B., TUFAN A., Elbeg S., Mercan R., Kucuk H., KÜÇÜKŞAHİN O., et al.
ARCHIVES OF RHEUMATOLOGY , vol.32, no.2, pp.118-122, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

86. Unexpected Brain Death in a 20 year old Man with Chiari Type I Malformation after Trauma Case Report and Review of Literature

KARA İ., KÜÇÜK H., YILDIRIM F.
American Journal of Medical Case Reports , vol.4, no.4, pp.140-143, 2016 (Peer-Reviewed Journal)

87. MARKERS OF SYSTEMIC INFLAMMATION IN BEHCET'S SYNDROME

Bitik B., Kucuk H., Varan O., Yesil N. K., Ozturk M. A., Haznedaroglu S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.34, no.6, 2016 (SCI-Expanded) identifier

88. Anakinra for the treatment of familial Mediterranean fever-associated spondyloarthritis

Varan O., Kucuk H., TUFAN A.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , vol.45, no.3, pp.252-253, 2016 (SCI-Expanded) identifier identifier identifier

89. EFFECT OF PULSE CYCLOPHOSPHAMIDE ON PARENCHYMAL NEUROLOGICAL INVOLVEMENT IN BEHCET SYNDROME

Seminur H., Berivan B., Ridvan M., Hamit K., Abdurrahman T., Berna G.
INTERNAL MEDICINE JOURNAL , vol.46, pp.47, 2016 (SCI-Expanded) identifier

90. Travma Hastalarında Skorlama Sistemlerinin Yoğun Bakım Mortalitesi Açısından Değerlendirilmesi

YILDIRIM F., KARA İ., KÜÇÜK H., KARABIYIK L., KATI İ.
Göğüs Kalp Damar Anestezi ve Yoğun Bakım Derneği Dergisi , vol.22, no.1, pp.29-33, 2016 (Peer-Reviewed Journal)

91. ASSOCIATION BETWEEN DISEASE ACTIVITY AND IL-17A/F, IL-23 AND IL-12/23 (p40) PRODUCTION BY PERIPHERAL BLOOD T LYMPHOCYTES IN BEHCET'S DISEASE

Atak Yücel A., Sonmez C., Yesii T. H., Kucuk H., Mercan R., Yucel E. A., et al.
JOURNAL OF IMMUNOLOGY , vol.196, no.Suppl 1, pp.194, 2016 (SCI-Expanded)

92. Differential diagnosis of elevated erythrocyte sedimentation rate and C-reactive protein levels: a rheumatology perspective

Bitik B., Mercan R., TUFAN A., Tezcan E., Kucuk H., Ilhan M. N., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.2, no.4, pp.131-134, 2015 (ESCI, TRDizin) Creative Commons License identifier identifier

93. Neutrophil/Lymphocyte Ratio: Could It be a Prognostic Indicator for Renal Outcome in Patients with Granulomatosis with Polyangiitis?

GÖKER B., HAZNEDAROĞLU Ş., Kucuk H., Varan O., Bitik B., TUFAN A., et al.
ARTHRITIS & RHEUMATOLOGY , vol.67, 2015 (SCI-Expanded) identifier

94. Comparison of Patient Costs in Internal Medicine and Anaesthesiology Intensive Care Units in a Tertiary University Hospital

Kara I., Yildirim F., Basak D. Y., Kucuk H., TÜRKOĞLU M., Aygencel G., et al.
TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION , vol.43, no.3, pp.142-148, 2015 (ESCI) Creative Commons License Sustainable Development identifier identifier identifier

95. VITAMIN B12, HOMOCYSTEINE AND METHYLMALONIC ACID LEVELS IN PATIENTS WITH NEURO-BEHCET'S SYNDROME

Bitik B., TUFAN A., Mercan R., Kucuk H., Kucuksahin O., Elbeg S., et al.
ANNALS OF THE RHEUMATIC DISEASES , vol.74, pp.1109, 2015 (SCI-Expanded) identifier

96. Comparison of Patient Costs in Internal Medicine andAnaesthesiology Intensive Care Units in a Tertiary UniversityHospital

KARA İ., YILDIRIM F., KÜÇÜK H., TÜRKOĞLU M., AYGENCEL BIKMAZ Ş. G., KATI İ., et al.
Turk J Anaesth Reanim , vol.43, pp.142-148, 2015 (Peer-Reviewed Journal)

97. Myasthenia gravis due to hydroxychloroquine

Varan O., Kucuk H., TUFAN A.
REUMATISMO , vol.67, no.3, pp.125, 2015 (ESCI) Creative Commons License identifier identifier identifier

98. Bir Üniversite Hastanesi İç Hastalıkları ve Anesteziyoloji Yoğun Bakım Ünitelerinde Hasta Maliyetlerinin Karşılaştırılması

KARA İ., YILDIRIM F., Yumuş Başak D., KÜÇÜK H., TÜRKOĞLU M., AYGENCEL BIKMAZ Ş. G., et al.
Turk J Anaesth Reanim , vol.43, pp.142-148, 2015 (Peer-Reviewed Journal)

99. MULTİTRAVMA SONRASI RABDOMİYOLİZ GELİŞEN OLGUDAAKUT BÖBREK YETMEZLİĞİ

KARA İ., KÜÇÜK H., KARABIYIK L., KATI İ.
Journal of Anesthesia , vol.22, no.3, pp.176-179, 2014 (Scopus)

100. Isolated hydatid cyst of uterine cervix: A case report

Kucuk Z., Karcaaltincaba D., Ergun Y., Dogan A. C., Caydere M., Kucuk H.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.40, no.4, pp.1157-1160, 2014 (SCI-Expanded) identifier identifier identifier

101. Neutrophil-Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis

Celikbilek M., Dogan S., ÖZBAKIR Ö., ZARARSIZ G., Kucuk H., GÜRSOY Ş., et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.27, no.1, pp.72-76, 2013 (SCI-Expanded) Creative Commons License identifier identifier identifier

102. IMPACT OF ARTERIAL STIFFNESS ON ADVERSE CARDIOVASCULAR OUTCOMES AND MORTALITY IN PERITONEAL DIALYSIS PATIENTS

SİPAHİOĞLU M. H., Kucuk H., Unal A., KAYA M., Oguz F., TOKGÖZ B., et al.
PERITONEAL DIALYSIS INTERNATIONAL , vol.32, no.1, pp.73-80, 2012 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

103. PULMONARY HYPERTENSION IN PERITONEAL DIALYSIS PATIENTS: PREVALENCE AND RISK FACTORS

Unal A., Sipahioglu M., Oguz F., Kaya M., Kucuk H., Tokgoz B., et al.
PERITONEAL DIALYSIS INTERNATIONAL , vol.29, no.2, pp.191-198, 2009 (SCI-Expanded) identifier identifier identifier

104. Comment on: Efficacy and safety of tocilizumab in Behcet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China

Kardas R. C., Küçük H.
RHEUMATOLOGY , vol.62, no.4, 1 (SCI-Expanded) identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 145

1. IMPORTANCE OF POTENTIAL PROTHROMBOTIC STATE MARKERS IN BEHÇET'S DISEASE AND CORRELATION WITH VASCULAR ULTRASOUND

Karadeniz H., Mammadov T., Cerit M., Avanoğlu Güler A., Yıldırım D., Vasi İ., et al.
13.ISSAID Meeting, Paris, France, 8 - 10 April 2025, pp.48, (Summary Text) Sustainable Development

2. TEDAVİYE DİRENÇLİ BİR NÖROBEHÇET OLGUSUNDA GELİŞEN UZUN-SEGMENT GENİŞ TRANSVERS MİYELİT

ERCAN M. B., KOÇER E. B., KÜÇÜK H.
4.Nöro-Romatoloji Sempozyumu, Eskişehir, Turkey, 15 - 17 November 2024, (Summary Text)

3. POS0857 REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

Demirci Yıldırım T., ERPEK KARAOVA E., ÖZDEMİR ULUSOY B., ÜNALDI E., SADİOĞLU ÇAĞDAŞ Ö., KARDAŞ R. C., et al.
EULAR 2024 |, Viyana, Austria, 08 October 2024, pp.1069-1070, (Full Text)

4. POS0218 VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OF TR-VaS COHORT

KOCAAYAN H., Durak Ediboğlu E., Demirci Yıldırım T., ÖZDEMİR B., Öğüt T. S., FIRLATAN B., et al.
EULAR 2024 |, Viyana, Austria, 12 June 2024, (Full Text)

5. AB1189 THE CIRCULATING LEVELS OF ENDOGENOUS EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID-DERIVED RESOLVINS ARE INCREASED IN SYSTEMIC SCLEROSIS: EVIDENCE FROM A SINGLE CENTRE COHORT

Avanoğlu Güler A., Çoşkun C., Karadeniz H., Gökgöz Acar S., Bilici R., Satış H., et al.
EULAR 2024 , Vienna, Austria, 12 June 2024, vol.83, pp.1930-1931, (Full Text) Creative Commons License

6. AB0483 THE IMPACT OF DELAY IN DIAGNOSIS ON BIOLOGICAL DMARD TREATMENT EFFICACY AND RETENTION RATES: REAL-LIFE DATA FROM NATIONWIDE TREASURE REGISTRY

KALYONCU U., AYAN G., DALKILIÇ H. E., COŞKUN B. N., PEHLİVAN Y., Yağız B., et al.
EULAR 2024 |, Viyana, Austria, 12 June 2024, (Full Text)

7. AB0127 EVALUATION OF TREATMENT COMPLIANCE IN GOUT PATIENTS: A PATIENT-CENTERED STUDY

Görgülü B., KARDAŞ R. C., Şeramet D. K., MERCAN R., TEZCAN M. E., KÜÇÜK H., et al.
EULAR 2024 |, Viyana, Austria, 12 June 2024, pp.1297, (Full Text)

8. AB1017 SLE PATIENTS EXHIBIT WALL THICKENING IN MAJOR VEINS ACROSS THE BODY

KARADENİZ H., YILDIRIM D., İbrahimhanlı N., koç kanık h. n., VASİ İ., DURAN R., et al.
EULAR 2024 |, Viyana, Austria, 12 June 2024, pp.1826-1827, (Full Text)

9. AB1271 EVALUATION OF SINONASAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS USING THE SNOT-22 QUESTIONNAIRE

baş d., KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., et al.
European Congress of Rheumatology (EULAR) 2024, Viyana, Austria, 12 - 15 June 2024, vol.83, pp.1979, (Summary Text)

10. AB0835 CANCER FREQUENCY IN CLOSE RELATIVES OF PATIENTS WITH SJÖGREN’S SYNDROME

Uğur Tuzcu T., KARDAŞ R. C., VASİ İ., YILDIRIM D., KAYA B., DURAN R., et al.
European Congress of Rheumatology (EULAR) 2024, Viyana, Austria, 12 - 15 June 2024, vol.83, pp.1715, (Summary Text)

11. AB1016 SERUM CXCL-13 LEVELS ARE ASSOCIATED WITH ACTIVE NEUROLOGICAL INVOLVEMENT IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

TUFAN A., YILDIRIM D., koç kanık h. n., DURAN R., KARDAŞ R. C., KAYA B., et al.
European Congress of Rheumatology (EULAR) 2024, Viyana, Austria, 12 - 15 June 2024, vol.83, pp.1826, (Summary Text)

12. AB0041 EVALUATING DISEASE ACTIVITY AND CARDIOVASCULAR RISK USING BIOMARKERS IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

YAZ AYDIN G., KARDAŞ R. C., VASİ İ., Altınsoy M. C., ERDEN A., KÜÇÜK H., et al.
European Congress of Rheumatology (EULAR) 2024, Viyana, Austria, 12 - 15 June 2024, vol.81, pp.1247, (Summary Text)

13. AB1421 DETERMINATION OF THE RELATIONSHIP BETWEEN SERUM PROTEIN 14-3-3 ETA LEVELS AND CLINICAL FEATURES OF THE DISEASE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

avcu a., YILDIRIM D., ERDEN A., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A.
European Congress of Rheumatology (EULAR) 2024, Viyana, Austria, 12 - 15 June 2024, vol.83, pp.2066, (Summary Text)

14. BİR OTOİMMUN HASTALIK BİRLİKTELİĞİ OLGUSU: GBS, OTOİMMUN ENSEFALİT VE SJÖGREN SENDROMU

Doğan K. A., Gökçe İlbasmış S., Arslan İ., Altıparmak T., Boran H. E., Batur Çağlayan H. Z., et al.
59. Ulusal Nöroloji Kongresi , Antalya, Turkey, 13 - 18 December 2023, pp.235, (Summary Text)

15. MS BENZERİ ÖZELLİK GÖSTEREN SLE'YE SEKONDER ANTİFOSFOLİPİD ANTİKOR SENDROMU OLGUSU

Ercan M. B., Koçer E. B., Kökmen H., Küçük H.
İSTANBUL VIII. MS DAYS , İzmir, Turkey, 16 - 18 October 2023, pp.33, (Full Text) Creative Commons License

16. IGG4 ilişkili hastalık ve çoklu malignite birlikteliği olan 2 olgu sunumu

DURAN R., ERDEN A., KÜÇÜK H.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

17. Serum high mobility box protein 1 (HMGB-1) düzeylerinin psoriasisli ve psöriatik artritli hastalar arasında karşılaştırılması

YILDIRIM D., BAYKUL M., AVANOĞLU GÜLER A., EDEK Y. C., GÜLENGÜL M., ADIŞEN E., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

18. Dirençli kutanöz ülserlerle seyreden bir anti MDA-5 pozitif dermatomiyozit olgusu

DURAN R., ERDEN A., KÜÇÜK H.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

19. Vaskülit ile karışabilen nadir bir durum; prolidaz enzim eksikliğ

Bozkurt H. H., Bozer M. N., YILDIRIM D., ERDEN A., KÜÇÜK H.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

20. VEXAS sendromunda adalimumab kullanımı: Tek merkez deneyimi

KARDAŞ R. C., ERDEN A., KÜÇÜK H.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

21. ANCA ilişkili vaskülit hastalarında osteoporozu ne kadar tanıyoruz? Çok merkezli retrospektif analiz

DEMİRCİ YILDIRIM T., DURAN E., SADİOĞLU ÇAĞDAŞ Ö., KARDAŞ R. C., KIZILTEPE M., EKİCİ M., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

22. GG4 ilişkili hastalıkta klinik fenotiplendrime ve yanıt değerlendirme: Tek merkez deneyimi

KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., ERDEN A., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

23. Spondiloartritlerin tedavisinde biyolojik DMARD sonrası tedavi seçimi

İŞBİLİR G. D., KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

24. Ulusal dev hücreli arterit veritabanı izlem verisi: Relaps oranı kontrollü çalışmalardan düşüktür

ALİBAZ ÖNER F., KELEŞOĞLU DİNÇER A. B., BALCI M. A., YARDIMCI G. K., ARMAĞAN B., KILIÇ L., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

25. Psoriasisli ve psöriatik artritli hastalarda serum CXCL13 düzeylerinin karşılaşt

YILDIRIM D., BAYKUL M., VASİ İ., GÜLENGÜL M., EDEK Y. C., KÜÇÜK H., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

26. Moyamoya sendromu ve antifosfolipid antikor sendromu birlikteliğ

VASİ İ., KARDAŞ R. C., YILDIRIM D., KAYA B., DURAN R., ERDEN A., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

27. Lupus nefriti ve renal tutulumlu sistemik vaskülitlerde SGLT2 inhibitörü kullanımı: Tek merkez deneyimi

KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., ERDEN A., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

28. Sistemik skleroz hastalarında SARS-COV-2 enfeksiyonun klinik özellikleri ve hastalık seyr

AVANOĞLU GÜLER A., VASİ İ., ÖZÇİMEN B., AYDOĞDU M. S., SARI A., Aliyeva N., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

29. Kolşisin intoleran Ailevi Akdeniz Ateşi hastalarında IL-1 antagonistinin monoterapi kullanımı ile etkin tedavi mümkün mü?

YILDIRIM D., KAYA B., VASİ İ., KARDAŞ R. C., DURAN R., KARADENİZ H., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

30. Peroksiredoksin-4: Sistemik skleroz ilişkili interstisyel akciğer hastalığında yeni bir biyomarker olabilir mi?

Alp G. T., VASİ İ., AVANOĞLU GÜLER A., KARADENİZ H., ERDEN A., KÜÇÜK H., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

31. Ailevi Akdeniz Ateşi hastalarında serum protein 14-3- 3 eta düzeyi ile hastalığın klinik özellikleri arasındaki ilişkinin belirlenmes

Avcu A., YILDIRIM D., ERDEN A., KÜÇÜK H., GÖKER B., ÖZTÜRK M. A., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

32. Vaskülit ve bağ doku hastalıkları ayırıcı tanısında nadir görülen bir olgu

KAYA B., YILDIRIM D., VASİ İ., KARDAŞ R. C., DURAN R., KÜÇÜK H., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

33. Anti sentetaz sendromunun klinik progresyonunda nadir bir sebep: Kızamık pnömonisi

Bozer M. N., Bozkurt H. H., ERDEN A., KÜÇÜK H.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

34. 2023 ACR/EULAR antifosfolipid antikor sendromu sınıflandırma kriterlerinin antifosfolipid antikoru pozitif hasta kohortundaki performansı

KARDAŞ R. C., VASİ İ., YILDIRIM D., KAYA B., DURAN R., ERDEN A., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 - 15 October 2023, (Full Text)

35. Still hastalığı ve enflamatuvar miyozitlerde PET’te dalak ortalama SUV değeri ile makrofaj aktivasyon sendromu riskinin ve mortalitenin değerlendirilmes

Zelyurt N., KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 11 October 2023, (Full Text)

36. L MARKER IN SYSTEMIC SCLEROSISASSOCIATED INTERSTITIAL LUNG DISEASE: PEROXIREDOXIN-4

Alp G. T., KARADENİZ H., VASİ İ., AVANOĞLU GÜLER A., ERDEN A., KÜÇÜK H., et al.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

37. COMPARISON OF SERUM CXCL13 LEVELS BETWEEN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

YILDIRIM D., VASİ İ., BAYKUL M., Gülengül M., Erdek Y., KÜÇÜK H., et al.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

38. CLINICAL CHARACTERISTICS AND CLINICAL OUTCOME OF SYSTEMIC SCLEROSIS OVERLAP SYNDROME (SSC-OS) IN TURKISH PATIENTS WITH SYSTEMIC SCLEROSIS

VASİ İ., KARDAŞ R. C., Ozkiziltas B., YILDIRIM D., Alp G. T., AVANOĞLU GÜLER A., et al.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

39. CLINICAL CHARACTERISTICS AND DISEASE COURSE BEFORE AND AFTER SARS-COV-2 INFECTION IN A LARGE COHORT OF SYSTEMIC SCLEROSIS PATIENTS

AVANOĞLU GÜLER A., Özcimen B., Aydoğdu M., SARI A., Aliyeva N., Tuzun N., et al.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

40. CHOICE OF BDMARD AFTER TNFI: DOES IT MATTER IN THE TREATMENT OF SPONDYLOARTHRITIS

İŞBİLİR G. D., KARDAŞ R. C., YILDIRIM D., Özkızıltaş B., VASİ İ., DURAN R., et al.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

41. DIFFUSE GENERALIZED VENULITIS AS THE PRIMARY PATHOLOGY OF BEHÇET’S DISEASE: A COMPREHENSIVE MAGNETIC RESONANCE VENOGRAPHY STUDY

KARADENİZ H., KÜÇÜK H.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

42. COLCHICINE INTOLERANT FAMILIAL MEDITERRANEAN FEVER PATIENTS RECEIVING IL-1 ANTAGONISTS: DO THEY MISS ADVANTAGE OF COMBINATION

YILDIRIM D., Özkızıltaş B., VASİ İ., KARDAŞ R. C., DURAN R., KARADENİZ H., et al.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May - 03 June 2023, (Full Text)

43. CHARACTERISTICS OF PATIENTS WHO RECEIVED BIOLOGICAL TREATMENT AFTER KIDNEY TRANSPLANTATION AND THE INCIDENCE OF SERIOUS INFECTIONS: A MULTICENTER STUD

KÜÇÜK H.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Summary Text)

44. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

BÖLEK E. Ç., AYAN G., BİLGİN E., KÜÇÜK H., ERDEN A., ALİBAZ ÖNER F., et al.
EULAR (Avrupa Romatoloji Kongresi), Milan, Italy, 31 May 2023, (Full Text)

45. AB0701 PERFORMANCE OF DRAFT 2022 ACR/EULAR CLASSIFICATION CRITERIA IN A TURKISH COHORT OF APL ANTIBODY POSITIVE PATIENTS

KARDAŞ R. C., YILDIRIM D., Özkızıltaş B., VASİ İ., DURAN R., KARADENİZ H., et al.
European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1554, (Summary Text)

46. AB0845 A NOVEL MARKER IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: PEROXIREDOXIN-4

ALP G. T., KARADENİZ H., VASİ İ., AVANOĞLU GÜLER A., ERDEN A., KÜÇÜK H., et al.
European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1635-1636, (Summary Text)

47. AB0940 TITLE: CHOICE OF BDMARD AFTER TNFI: DOES IT MATTER IN THE TREATMENT OF SPONDYLOARTHRITIS?

İŞBİLİR G. D., KARDAŞ R. C., YILDIRIM D., Özkızıltaş B., VASİ İ., DURAN R., et al.
European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1687-1688, (Summary Text)

48. AB0922 CLINICAL CHARACTERISTICS AND CLINICAL OUTCOME OF SYSTEMIC SCLEROSIS OVERLAP SYNDROME (SSC-OS) IN TURKISH PATIENTS WITH SYSTEMIC SCLEROSIS

VASİ İ., KARDAŞ R. C., DURAN R., Özkızıltaş B., YILDIRIM D., ALP G. T., et al.
European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1678, (Summary Text)

49. AB1461 COLCHICINE INTOLERANT FAMILIAL MEDITERRANEAN FEVER PATIENTS RECEIVING IL-1 ANTAGONISTS: DO THEY MISS ADVANTAGE OF COMBINATION

YILDIRIM D., Özkızıltaş B., VASİ İ., KARDAŞ R. C., DURAN R., KARADENİZ H., et al.
European Congress of Rheumatology (EULAR) 2023, Milan, Italy, 31 May - 03 June 2023, vol.82, pp.1958-1959, (Summary Text)

50. Sistemik lupus eritematozuslu hastalarda gebelik sonuçları ve takrolimus deneyimi

VASİ İ., YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., DURAN R., Alp G. T., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 26 October 2022, (Full Text)

51. İnterlökin 1 blokeri kullananlarda hasar indeksi artisinin izlemi: Tek merkez deneyimi

YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., VASİ İ., KÜÇÜK H., ÖZTÜRK M. A., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 26 October 2022, (Full Text)

52. Renal transplantasyon sonrası biyolojik tedavi ile izlenen hastaların özellikleri ve ciddi enfeksiyon sıklığı: Çok merkezli çalışma

DEMİRCİ YILDIRIM T., OĞUZ KÖKOĞLU E., COŞKUN B. N., YILDIRIM D., KÜÇÜK H., ŞENEL S., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 26 October 2022, (Full Text)

53. Merkezimizde takipli erişkin başlangıçlı Still hastalığı olanların tedavi yanıtları

YILDIRIM D., VASİ İ., ÖZKIZILTAŞ B., KARDAŞ R. C., AVANOĞLU GÜLER A., KARADENİZ H., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 26 October 2022, (Full Text)

54. EVALUATING THE CLINICAL UTILITY OF PATIENT ACCEPTABLE SYMPTOM STATE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

DEMİREZEN A., AVANOĞLU GÜLER A., KARADENİZ H., YILDIRIM D., KÜÇÜK H., ÖZTÜRK M. A., et al.
EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Summary Text)

55. DETERMINING THE RELATIONSHIP BETWEEN SERUM INTERLEUKIN 33 LEVELS AND CLINICAL FEATURES OF THE DISEASE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

DEMİREZEN A., AVANOĞLU GÜLER A., KARADENİZ H., YILDIRIM D., KÜÇÜK H., KAVUTÇU M., et al.
EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Summary Text)

56. ATTACKS OF MYALGIA IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER: OTHER THAN CALF PAIN

YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., VASİ İ., KÜÇÜK H., ÖZTÜRK M. A., et al.
EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Full Text)

57. DO IL-1 ANTAGONISTS DEFINITELY PROTECT FROM THE DEVELOPMENT OF NEW DAMAGE: A SINGLECENTER STUDY

YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., VASİ İ., KÜÇÜK H., ÖZTÜRK M. A., et al.
EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Full Text)

58. SERUM INTERLEUKIN 37 LEVELS IN FAMILIAL MEDITERRANEAN FEVER PATIENTS AND ASSOCIATION WITH CLINICAL FEATURES

Fincan A., KAVUTÇU M., ATAŞ N., BABAOĞLU H., Salman R. B., SATIŞ H., et al.
EULAR (Avrupa Romatoloji Kongresi), Denmark, 01 June 2022, (Summary Text)

59. Ailesel Akdeniz ateşi hastalarındakronik artrit: Klinik özellikler ve tedavi

AVANOĞLU GÜLER A., COŞKUN Ç., ÜNAL S., Tahta E., KARADENİZ H., Salman R. B., et al.
Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

60. Nadir görülen bir olgu sunumu: VEXAS sendromu

YILDIRIM D., AKCAN E., PAMUK İ., Gökhan S., KÜÇÜK H., TUFAN A., et al.
Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

61. Antisentetaz sendromu- hemakromatozis birlikteliği: Nadir görülen bir olgu sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., ÖZTÜRK M. A.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 29 September 2021, (Full Text)

62. AAA hastalarında gastrointestinal sistem tutulumu

KIZMAZ E., YILDIRIM D., TUFAN A., ÖZTÜRK M. A., GÖKER B., KÜÇÜK H., et al.
Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

63. Sistemik lupus eritematozus hastalarında akalküloz kolesistit: iki olgu sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., Tahta E., GÖKER B., ÖZTÜRK M. A., et al.
Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

64. Akciğer skuamöz hücreli kanseri- granülomatoz polianjiitis birlikteliği: Olgu sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., ÖZTÜRK M. A.
Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text) Sustainable Development

65. Sistemik lupus eritematozusda prognostik nutrisyonel indeksin hastalık aktivitesi ile olan ilişkisinin araştırılması: Tek merkez deneyimi

Salman R. B., AVANOĞLU GÜLER A., KARADENİZ H., SATIŞ H., KÜÇÜK H., HAZNEDAROĞLU Ş., et al.
Ulusal Romatoloji Kongresi, Antalya, Turkey, 29 September 2021, (Full Text) identifier

66. Sistemik lupus eritematozus relapsing polikondrit birlikteliği: İki olgu Sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., ÖZTÜRK M. A.
Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

67. Tedaviye dirençli Takayasu arteritinde tofasitinib kullanımı: iki olgu sunumu

YILDIRIM D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., ÖZTÜRK M. A.
Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

68. Nadir görülen birliktelik: İmmünoglobulin G4 ilişkili hastalıkta anjiyomyomatoid fibröz histiyositom olgu sunumu

Baş D., Yıldırım D., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., et al.
Ulusal Romatoloji Kongresi 2021, Antalya, Turkey, 29 September 2021, (Full Text)

69. GEBELERDE ANTİ TNF NEDEN KULLANMAYALIM?

KÜÇÜK H.
7. İyi Klinisyenlik İçin İpuçları Toplantısı, Girne, Cyprus (Kktc), 17 - 19 January 2020, (Full Text)

70. Etanercept-Induced Paradoxical Acute Pancreatitis

KUDAŞ Ö., KÜÇÜK H.
International INTERNAL MEDICINE TRAINING MEETINGS - 17, PRAG, Czech Republic, 8 - 10 March 2019, (Full Text)

71. Tuberculosis in a Case with Antiphospholipid Syndrome Heart Valve Coverage, Case Report

KÜÇÜK H.
International INTERNAL MEDICINETRAINING MEETINGS - 16, 22 - 24 February 2019, (Full Text) Sustainable Development

72. Eriflkin ailesel Akdeniz atefli hastalar›nda kronikinflamasyon: Altta yatan nedenler ve amiloidozla iliflkisi

VARAN Ö., KÜÇÜK H., BABAOĞLU H., TECER D., ATAŞ N., SALMAN R. B., et al.
2018 ULUSAL ROMATOLOJİ KONGRESİ, BODRUM, Turkey, 26 - 30 September 2018, (Full Text)

73. Behçet hastalığı ve oftalmoplejik migren birlikteliği Olgu sunumu

KUDAŞ Ö., KÜÇÜK H.
2018 ULUSAL ROMATOLOJİ KONGRESİ, BODRUM, Turkey, 26 - 30 September 2018, (Full Text)

74. PS-015 Erişkin ailesel Akdeniz ateşi hastalarında kronik inflamasyon: Altta yatan nedenler ve amiloidozla ilişkisi

VARAN Ö., KÜÇÜK H., BABAOĞLU H., TECER D., ATAŞ N., Salman r. b., et al.
XIX. Ulusal Romatoloji Kongresi, Turkey, 26 - 30 September 2018, (Summary Text)

75. BEHÇET HASTALIĞI DERIN VEN TROMBUSUNDEAZATIOPÜRIN TEDAVISI VE WARFARIN BIRLIKTEKULLANIMININ ZORLUKLARI

KÜÇÜK H.
4. İlaç ve TedaviKongresi19 – 23 Eylül 2018Elexus Hotel, Girne, K.K.T.C.“Akılcı İlaç Kullanımı, Girne, Cyprus (Kktc), 19 - 23 September 2018, (Full Text)

76. Behcet Disease and Periodontal condition

ORDUYILMAZ F., ÖZMERİÇ KURTULUŞ N., ELGÜN ÜLKAR S., GÜRBÜZ S., KÜÇÜK H., Bitik B., et al.
Europerio 9, 20 - 23 June 2018

77. ON DEMAND USE OF ANAKINRA FOR THE ATTACKS OF FAMILIAL MEDITERRANEAN FEVER (FMF)

Babaoglu H., Varan O., Kucuk H., Atas N., Satis H., Salman R. B., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.507-508, (Summary Text) Creative Commons License identifier

78. THE PREVALENCE OF SPONDYLOARTHROPATHY IN PATIENTS WITH TAKAYASU ARTERITIS

Guzel S., Armagan B., Varan O., Erden A., Kucuk H., Babaoglu H., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.429, (Summary Text) Creative Commons License identifier

79. CANAKINUMAB USE IN ADULT FAMILIAL MEDITERRANEAN FEVER PATIENTS: A LARGE SINGLE CENTRE EXPERIENCE

Babaoglu H., Varan O., Kucuk H., Alas N., Satis H., Salman R. B., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.1158, (Summary Text) Creative Commons License identifier

80. EFFECT OF INTERLEUKIN-1 ANTAGONISTS ON THE QUALITY OF LIFE IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

Varan O., Kucuk H., Babaoglu H., Atas N., Satis H., Salman R. B., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 13 - 16 June 2018, vol.77, pp.502, (Summary Text) Creative Commons License identifier

81. ANCA İlişkli Vaskülitler

KUDAŞ Ö., KÜÇÜK H.
5. İyi Klinisyenlik İçin İpuçları Toplantısı, Girne, Cyprus (Kktc), 19 - 21 January 2018, (Full Text)

82. Behçet Hastalarında Vasküler Tutulumda Antikoagülan KullanmanınEtkinlik ve Riskleri.

KÜÇÜK H.
5. İyi Klinisyenlik İçin İpuçları Toplantısı, Girne, Cyprus (Kktc), 19 - 21 January 2018, (Full Text)

83. Budd-Chiari Syndrome in Behçet’s Disease: A Retrospective Multicenter Study

AKYOL L., TOZ B., Bayindir O., ZENGİN O., CANSU Ü., YİĞİT M., et al.
EULAR 2017 Annual Europian Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.327-328, (Summary Text)

84. BUDD-CHIARI SYNDROME IN BEHCET'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY

Akyol L., Toz B., Bayindir O., Zengin O., Cansu D. U., Yigit M., et al.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.327-328, (Summary Text) Creative Commons License identifier

85. Relationship Between Periodontal Findings And Serum Inflammatory Markers In Turkish Granulοmatosis With Polyangiitis Patients

GÜRBÜZ S., ÖZMERİÇ KURTULUŞ N., KÜÇÜK H., ORDUYILMAZ F., GÖKER B.
22nd Bass Congress, 4 - 07 May 2017, (Summary Text)

86. IMPACT OF DISEASE ON FAMILY AND SOCIAL LIFE IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Babaoglu H., Varan O., Guven S. C., Tecer D., Kucuk H., TUFAN A., et al.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.1216, (Summary Text) Creative Commons License Sustainable Development identifier

87. SERUM DEFENSIN LEVEL IN SYSTEMIC SCLEROSIS PATIENTS

Emiroglu T., Kucuk H., Goker B., Haznedaroglu S., Pasaoglu H., Varan O., et al.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.1260-1261, (Summary Text) Creative Commons License identifier

88. PREDICTIVE VALUE OF PLATELET TO LYMPHOCYTE RATIO IN RENAL INVOLVEMENT IN PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS

Kucuk H., Tecer D., Varan O., Babaoglu H., Guven S. C., TUFAN A., et al.
Annual European Congress of Rheumatology, Madrid, Spain, 14 - 17 June 2017, vol.76, pp.608-609, (Summary Text) Creative Commons License identifier

89. Nailfold Capillaroscopy Findings in a Patient with Port - Wine Stain

GÜVEN S. C., KÜÇÜK H., TUFAN A.
MIRCIM 2017 TIHUD-TIP Joint Meeting, 11 - 14 May 2017, (Summary Text)

90. RELATIONSHIP BETWEEN PERIODONTAL FINDINGS AND SERUM INFLAMMATORY MARKERS IN TURKISH GRANULOMATOSIS WITH POLYANGIITIS PATIENTS

GÜRBÜZ S., ÖZMERİÇ KURTULUŞ N., KÜÇÜK H., ORDUYILMAZ F., GÖKER B.
22. BaSS Congress, SELANİK, Greece, 4 - 07 May 2017, (Full Text)

91. AN EASY METHOD FOR TRACKING ATTACK DATA OF AUTOINFLAMMATORY DISEASES: AUTOINFLAMMATORY DISEASE DIARY (AIDD) APPLICATION

TUFAN A., KÜÇÜK H., VARAN Ö., BABAOĞLU H.
9th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases., 4 - 07 May 2017, (Full Text)

92. WEGENER HASTALARINDA SERUM FERRİTİN DÜZEYİ İLE HASTALIK PROGRESYONU ARASINDAKİ İLİŞKİ

KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., BERİVAN B., GÖKER B., et al.
ULUSAL ROMATOLOJİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

93. Kronik Plevral Efüzyon Araştırılan FMF Hastasında Mezotelyoma Olgu Sunumu

KÜÇÜK H., VARAN Ö., TUFAN A., HAZNEDAROĞLU Ş., ÖZTÜRK M. A., GÖKER B.
ULUSAL ROMATOLOJİ KONGRESİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

94. Kadın Hastalarda Sistemik Lupus Eritematosus un Aile ve Sosyal Yaşama Etkileri

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B.
ULUSAL ROMATOLOJİ KONGRESİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

95. Sistemik Lupus Eritematosus ve Hiperimmünglobulin M Sendromu Nadir Görülen Bir Birliktelik

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B.
ULUSAL ROMATOLOJİ KONGRESİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

96. otimmun iç kulak hastalığı olgu sunumu

GÜVEN S. C., KÜÇÜK H., TECER D., TUFAN A., VARAN Ö., GÖKER B.
ulusal romatoloji kongresi, Turkey, 24 - 30 October 2016, (Full Text)

97. SİSTEMİK SKLEROZLU HASTALARDA SERUM DEFENSİN DÜZEYLERİNİN BELİRLENMESİ

EMİROĞLU T., KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., et al.
ULUSAL ROMATOLOJİ, Turkey, 24 - 30 October 2016, (Full Text)

98. Romatoid Artrit Dirsek Tutulumu Azathioprın Tedavisi

KÜÇÜK H., VARAN Ö., TUFAN A., HAZNEDAROĞLU Ş., ÖZTÜRK M. A., GÖKER B.
ULUSAL ROMATOLOJİ KONGRESİ 2016, Turkey, 24 - 30 October 2016, (Full Text)

99. Orbital inflamatuar lezyonların ayırıcı tanısında nadir bir klinik tablo Tolosa Hunt sendromu

GÜVEN S. C., KÜÇÜK H., VARAN Ö., TECER D., BABAOĞLU H., TUFAN A.
ULUSAL ROMATOLOJİ, Turkey, 24 - 30 October 2016, (Full Text)

100. Chorea Associated With Antiphospholipid Syndrome In Two Young Women With History of Pregnancy Losses

GÖKER B., KÜÇÜK H., FEYZA NUR K., VARAN Ö., TUFAN A., ÖZTÜRK M. A., et al.
15. Uluslararası Antifosfolipid Sendromu Kongresi, 21 - 24 September 2016, (Full Text) Sustainable Development

101. Chorea associated with antiphoapholipid symdrome in 2 young women with pregnancy losses

GÖKER B., KELEZ F. N., KÜÇÜK H., VARAN Ö., TUFAN A., ÖZTÜRK M. A., et al.
15TH INTERNATIONAL CONGRESS ON ANTIPHOSPHOLIPID SYNDROME, 21 - 24 September 2016, (Summary Text) Sustainable Development

102. IgM nephropathy in a patient with antiphospholipid syndrome

KÜÇÜK H., KELEZ F. N., VARAN Ö., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.
15TH INTERNATIONAL CONGRESS ON ANTIPHOSPHOLIPID SYNDROME, 21 - 24 September 2016, (Summary Text)

103. Markers of inflammation in Behçet s syndrome

BİTİK B., KÜÇÜK H., VARAN Ö., YEŞİL N., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.
17th International Conference on Behçet's Disease, 15 - 17 September 2016, (Summary Text)

104. ınterstisyel akciğer hastalıklarının ayırıcı tanısında nadir görülen bir durum sekestrasyon

merve ecem erdoğan y., KÜÇÜK H., VARAN Ö., TUFAN A., GÖKER B.
ulusal romatoloji kongresi, Turkey, 24 - 30 June 2016, (Full Text)

105. AB0526 Serum Ferritin as A Marker of Activity in Patients with Anca Associated Vasculitis

KÜÇÜK H., VARAN Ö., BERİVAN B., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş., et al.
eular KONGRE, 8 - 11 June 2016, (Full Text)

106. MARKERS OF SYSTEMIC INFLAMMATION IN BEHCET S SYNDROME

BERİVAN B., KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., et al.
EULAR KONGRESİ, 8 - 11 June 2016, (Full Text)

107. AB0535 Assessment of Cardiovascular Risk in Patients with Granulomatosis with Poliangiitis Using The Score Risk Index

BERİVAN B., KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., et al.
EULARr KONGRE, 8 - 11 June 2016, (Full Text)

108. Serm ferritin asa marker of activity in patients with ANCA associated vasculitis

KÜÇÜK H., VARAN Ö., BİTİK B., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş., et al.
EULAR 2016 European League Against Rheumatism, 8 - 11 June 2016, (Summary Text)

109. Assessment of cardiovascular risk in patients with granulomatosis with polyangiitis using the score risk index

BİTİK B., KÜÇÜK H., VARAN Ö., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., GÖKER B., et al.
EULAR 2016 European League Against Rheumatism, 8 - 11 June 2016, (Summary Text)

110. ASSESSMENT OF CARDIOVASCULAR RISK IN PATIENTS WITH GRANULOMATOSIS WITH POLIANGIITIS USING THE SCORE RISK INDEX

Bitik B., Kucuk H., Varan O., Ozturk M. A., Haznedaroglu S., Goker B., et al.
Annual European Congress of Rheumatology (EULAR), London, Canada, 8 - 11 June 2016, vol.75, pp.1088, (Summary Text) identifier

111. SERUM FERRITIN AS A MARKER OF ACTIVITY IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

Kucuk H., Varan O., Bitik B., Ozturk M. A., Goker B., Haznedaroglu S., et al.
Annual European Congress of Rheumatology (EULAR), London, Canada, 8 - 11 June 2016, vol.75, pp.1084-1085, (Summary Text) identifier

112. EFFECT OF PULSE CYCLOPHOSPHAMİDE ON PARENCHYMAL NEUROLOGIKAL INVOLVEMENT IN BEHCET SYNDROME

HAZNEDAROĞLU Ş., BİTİK B., RIDVAN M., KÜÇÜK H., TUFAN A., GÖKER B.
Australian Rheumatology Association in conjunction with Rheumatology Helt Professionals Association 57. Annual Scientific Meeting, 30 April - 04 May 2016, (Full Text)

113. ASSOCIATION BETWEEN DISEASE ACTIVITY AND IL-17A/F, IL-23 AND IL-12/23 (p40) PRODUCTION BY PERIPHERAL BLOOD T LYMPHOCYTES IN BEHCET'S DISEASE

Yucel A., Sonmez C., Yesii T. H., Kucuk H., Mercan R., Yucel E. A., et al.
Annual Meeting of the American-Association-of-Immunologists (AAI), Washington, United States Of America, 13 - 17 May 2016, vol.196, (Summary Text) identifier

114. Association between disease activity and IL 17A F IL 23 and IL 12 23 p40 production by peripheral blood T lymphocytes in Behçet s disease

ATAK YÜCEL A., SÖNMEZ C., YEŞİL T. H., KÜÇÜK H., mercan r., YÜCEL A. E., et al.
Immunology 2016, Annual Meeting of The American association of Immunologists (AAI), 13 - 17 May 2016, (Summary Text)

115. Associaiton between disease activity and IL 17A F IL 23 and IL 12 23 p40 production by peripheral blood T lymphocytes in Behçet s disease

ATAK YÜCEL A., SÖNMEZ C., YEŞİL T. H., KÜÇÜK H., mercan r., YÜCEL A. E., et al.
Immunology 2016, Annual Meeting of The American association of Immunologists (AAI), 13 - 17 May 2016, (Summary Text)

116. Lipopolisakkarid indükte sepsis ratmodelinde erken dönem tanıda iskemikmodifiye albumin

PAMPAL H. K., KARA İ., UYAR GÖÇÜN F. P., ZERMAN A., EMMEZ G., KOCABIYIK M., et al.
12.ULUSAL DAHİLİ CERRAHİ BİLİMLER YOĞUN BAKIM KONGRESİ, Turkey, 4 - 07 November 2015, (Summary Text)

117. Behçet Hastalığı Aktivitesi ile Periferik Kan Lenfosit İL-17A/F, İL-23, İL-35 ve İL-12/23(P40) Üretimi İlişkisi (Poster)

SÖNMEZ C., ATAK YÜCEL A., Yesil T. H., KÜÇÜK H., SEZGİN B., MERCAN R., et al.
3. Ulusal Klinik Mikrobiyoloji Kongresi, Antalya, Turkey, 18 - 22 November 2015, (Summary Text)

118. GranÜlomatöz polianjitis hastasInda gastrointestinalsistem tutulumu: Olgu sunumu

KÜÇÜK H., VARAN Ö., TUFAN A., TECER D., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.
2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

119. Anakinra tedavisi ile remisyona giren FMF ilişlkilispondilit

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş.
2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

120. Sistemik lupus eritematozus göz tutulumu

KÜÇÜK H., VARAN Ö., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., HASANREİSOĞLU C. M., et al.
2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

121. Melkersson-Rosenthal sendromu ve oligoartritliolgu sunumu

KÜÇÜK H., VARAN Ö., BİTİK B., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.
2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

122. Hareket kısıtlılığına neden olan yaygın kalsinozis cutis

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş.
2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

123. Hidroksiklorokin kullanımına bağlı gelişenmyastenia gravis

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş.
2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

124. Parenkimal nörolojik tutulumu olan behçet hastalarındaserum vitamin B12, homosistein ve metilmalonik asitdüzeylerinin sağlıklı kontroller ile karşlılaştırılması

BİTİK B., TUFAN A., MERCAN R., Elbeğ Ş., KÜÇÜK H., KÜÇÜKŞAHİN O., et al.
Ulusal Romatoloji Kongresi 2015, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

125. Anakinra tedavisi sonrası klinik remisyon sağlananMilwaukee shoulder sendromu

VARAN Ö., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A., GÖKER B., HAZNEDAROĞLU Ş.
2015 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

126. Granülomatöz polianjitis hastasında mukoza vecilt tutulumu olgu sunumu

KÜÇÜK H., VARAN Ö., TECER D., TUFAN A., ÖZTÜRK M. A., HAZNEDAROĞLU Ş., et al.
2015 Ulusal Romatoloji Kongresi, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

127. ANCA iliflkili vaskülitlerde nötrofil-lenfosit oran›n›n yeri

KÜÇÜK H., GÖKER B., DUMLUDAĞ B., ERTEN Y., BİTİK B., MERCAN R., et al.
2015 ULUSAL ROMATOLOJİ, Antalya, Turkey, 28 October - 01 November 2015, (Full Text)

128. magnetic resonance imaging features of familial mediterranean fever associated spondyloarthropathies

turan a., mercan r., berivan b., KÜÇÜK H., ÖZTÜRK M. A., TUFAN A.
8th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases, 30 September - 03 October 2015, (Summary Text)

129. underlying causes of persistantly elevated acute phase reactants in patients with familial mediterranean fever

mercan r., bitik b., eren r., DUMLUDAĞ B., turan a., KÜÇÜK H., et al.
8th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases, 30 September - 03 October 2015, (Summary Text)

130. Magnetic resonance imaging features of Familial Mediterranean Fever associated spondyloarthritis

TURAN A., RIDVAN M., BERİVAN B., KÜÇÜK H., ÖZTÜRK M. A., TUFAN A.
10.1186/1546-0096-13-S1-P114, 30 September - 03 October 2015, vol.13, pp.114 Creative Commons License

131. Underlying causes of persistently elevated acute phase reactants in patiens with Familial Mediterranean Fever

RIDVAN M., BERİVAN B., EREN SADİOĞLU R., DUMLUDAĞ B., TURAN A., KÜÇÜK H., et al.
8th International Congress of Familial Mediterranean Fever and Systemic Auto-Inflammatory Diseases, 30 September - 03 October 2015, vol.13, pp.139

132. vitaminB12 homocystein and methylmalonic acid levels in patients with neuro behcet s syndrome

bitik b., TUFAN A., mercan r., KÜÇÜK H., KÜÇÜKŞAHİN O., ÖZTÜRK M. A., et al.
EULAR european league againts rheumatism annual meeting, 10 - 13 June 2015, (Summary Text)

133. Neutrophil Lymphocyte Ratio Could It be a Prognostic Indicator for Renal Outcome in Patients with Granulomatosis with Polyangiitis

GÖKER B., HAZNEDAROĞLU Ş., KÜÇÜK H., VARAN Ö., BERİVAN B., TUFAN A., et al.
Neutrophil/Lymphocyte Ratio: Could It be a Prognostic Indicator for Renal Outcome in Patients with Granulomatosis with Polyangiitis?, 6 - 11 November 2015, vol.67

134. ANTİ TÜMÖR NEKROZİS FAKTÖR KULLANAN BİRHASTADA GELİŞEN ATİPİK YERLEŞİMLİ HODGKİNLENFOMA

MERCAN R., BİTİK B., KÜÇÜK H., TECER D., TUFAN A., ÖZTÜRK M. A., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)

135. SİSTEMİK LUPUS ERİTEMATOZUS HASTALARINDAHASTALIK AKTİVASYONU İLE MEAN PLATELET VOLUMARASINDAKİ İLİŞKİ

KÜÇÜK H., BİTİK B., MERCAN R., TECER D., KAYA A., GÖKER B., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)

136. KRONİK LENFOSİTİ LÖSEMİ İLE KOMPLİKE BİRANKİLOZAN SPONDİLİT HASTASINDA ETANERCEPTTEDAVİSİ

MERCAN R., BİTİK B., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., GÖKER B., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)

137. SJÖGREN SENDROMLU HASTALARDA OTOİMMUNHEPATİT VE PRİMER BİLİER SİROZ SIKLIĞI

TECER D., KÜÇÜK H., MERCAN R., BİTİK B., TUFAN A., ÖZTÜRK M. A., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Summary Text)

138. HİPERİMMÜNGLOBULİN M SENDROMLU BİRHASTADA SERONEGATİF EROZİV ARTRİT: OLGUSUNUMU

KÜÇÜK H., BİTİK B., TECER D., GÖKER B., HAZNEDAROĞLU Ş., ÖZTÜRK M. A., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)

139. NOTALGİA PARESTETİKA: OLGU SUNUMU

TECER D., KÜÇÜK H., MERCAN R., BİTİK B., TUFAN A., ÖZTÜRK M. A., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)

140. BAĞ DOKU HASTALIĞINA BAĞLI İNTERSTİSYELAKCİĞER TUTULUMU OLAN HASTALARIN KLİNİK VERADYOLOJİK ÖZELLİKLERİ

BİTİK B., TÜRK M., TUFAN A., KÖKTÜRK N., MERCAN R., KÜÇÜK H., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)

141. SİSTEMİK LUPUS ERİTEMATOZUS’DA SERUM 25 (OH)D3 DÜZEYİ İLE HASTALIK AKTİVASYONU ARASINDAKİİLİŞKİ

BİTİK B., KAYA A., TEZCAN M. E., TUFAN A., MERCAN R., KÜÇÜK H., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)

142. PRİMER SJÖGREN SENDROMU’NUN PATOBİYOLOJİKSEYRİNDE ANTİSENTROMER ANTİKOR POZİTİFLİĞİ VEIGG4

GÜZEL E., BİTİK B., BAŞTÜRK B., KARAKUŞ R., MERCAN R., TUFAN A., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)

143. Bağ Doku Hastalığına Bağlı İnterstisyel Akciğer Tutulumu Olan Hastaların Klinik ve Radyolojik Özellikleri

BİTİK B., TÜRK M., TUFAN A., KÖKTÜRK N., MERCAN R., KÜÇÜK H., et al.
XV. Ulusal Romatoloji Kongresi 2014, Turkey, 29 October - 02 November 2014, (Summary Text)

144. SİSTEMİK LUPUS ERİTEMATOZUSA EŞLİK EDEN İKİARAKNOİDİT OLGUSU

MERCAN R., BİTİK B., KÜÇÜK H., TUFAN A., COŞKUN Ö., ÖZTÜRK M. A., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 - 02 October 2014, (Full Text)

145. SARKOİDOZ ATİPİK PREZENTASYON

TECER D., BİTİK B., KÜÇÜK H., TUFAN A., HAZNEDAROĞLU Ş., ÖZTÜRK M. A., et al.
2014 ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Turkey, 29 October - 02 November 2014, (Full Text)
Books 12

1. ROMATOLOJIK HASTALIKLARDA AKCIĞER TUTULUMU

Öztürk M. A. (Member Of Editors Board), Yılmaz Demirci N. (Member Of Editors Board), Küçük H. (Member Of Editors Board)
Hipokrat Yayınları, Ankara, 2024 Creative Commons License

2. Erişkin Başlangıçlı Still Hastalığı

KARADENİZ H., KÜÇÜK H.
in: Vakalarla Klinik Romatoloji 3, Süleyman Serdar Koca, Ahmet Karataş, Editor, Nobel Tıp Kitabevi, İstanbul, pp.47-62, 2023

3. AKSİYEL SPONDİLOARTRİT GÜNCEL TEDAVİ KLAVUZLARI

KARADENİZ H., KÜÇÜK H.
in: Romatolojide Güncel Klavuzlar, Adem Küçük, Emine Duygu Ersözlü, Sibel Bakırcı, Editor, Akademisyen yayınevi, Ankara, pp.1-5, 2023

4. Ekstremite Muayenesi

KÜÇÜK H.
in: İç Hastalıklarında Anamnez Alma ve Fizik Muayene, Erten Yasemin, Editor, Nobel, Ankara, pp.201-231, 2023

5. PSORİATİK ARTRİT TANISI KOYARKEN ANAMNEZ VE FİZİK MUAYENEDE NELERE DİKKAT EDİLMELİDİR?

KÜÇÜK H.
in: A' DAN Z'YE PSORİATİK ARTRİT EL KİTABI, Prof. Dr. Kemal Nas, Dr. Emre Uzun, Editor, Sakarya Üniversitesi Yayınları, Sakarya, pp.56-61, 2022

6. COVID-19 Tedavisinde kullanılan anti-romatizmal ilaçlar

KÜÇÜK H., TECER D.
in: COVID-19 ve Romatoloji, Yılmaz S, Editor, Türkiye Klinikleri, Ankara, pp.49-58, 2021 Sustainable Development

7. Romatolojik Hastalıkların Gebelik veLaktasyon Dönemlerinde Yönetimi

KÜÇÜK H.
in: BÜTÜNCÜL TIP Birinci Basamakta ve Aile Hekimliğinde Güncel Tanı-Tedavi, Doç.Dr. Aydın ÇIFCI, Prof. Dr. Adem ÖZKARA, Dr. Öğr. Üyesi Serkan TURSUN, Uz. Dr. Bulut DEMİREL, Prof. Dr. Murat KEKİLLİ, Editor, NOBEL TIP KİTABEVLERİ, Ankara, pp.1628-1631, 2020

8. Enfamatuvar Kas Hastalıkları

KÜÇÜK H.
in: BÜTÜNCÜL TIP Birinci Basamakta ve Aile Hekimliğinde Güncel Tanı-Tedavi, Baş Editör Doç.Dr. Aydın ÇIFCI, Editörler: Prof. Dr. Adem ÖZKARA, Dr. Öğr. Üyesi Serkan TURSUN, Uz. Dr. Bulut DEMİREL,Prof. Dr. Murat KEKİLLİ, Editor, Nobel Tıp, Ankara, pp.1625-1627, 2020

9. Raynaud Sendromu

Küçük H.
in: BÜTÜNCÜL TIP Birinci Basamakta ve Aile Hekimliğinde Güncel Tanı-Tedavi, Baş Editör: Doç.Dr. Aydın ÇIFCI,Editörler: Prof. Dr. Adem ÖZKARA,Dr. Öğr. Üyesi Serkan TURSUN,Uz. Dr. Bulut DEMİREL,Prof. Dr. Murat KEKİLLİ, Editor, Nobel Yayınevi, Ankara, pp.1632-1634, 2019 Creative Commons License

10. Romatolojik Hastalıklarda Beslenme

Küçük H.
in: Dahili Hastalarda Özel Beslenme ve Diyet Yönetimi, Can Özlü, Editor, Akademi Kitabevi Yayınları, Ankara, pp.353-356, 2019

11. Antifosfolipid Sendromunda Prognostik Faktörler

Küçük H., Yazıcı A., Erkan D.
in: Türkiye Klinikleri Romatoloji - Özel Konular, Berna Göker, Editor, Türkiye Klinikleri, Ankara, pp.31-36, 2019 Creative Commons License

12. Eklem ağrısı, ateş, kas ağrısı ve halsizlik yakınmaları ile başvuran,51 yaşında kadın hasta

KÜÇÜK H.
in: ROVAG 6, Prof. Dr. Mehmet Sayarlıoğlu, Editor, ROVAG, pp.179-188, 2016
Metrics

Publication

263

Publication (WoS)

96

Publication (Scopus)

86

Citation (WoS)

744

H-Index (WoS)

16

Citation (Scopus)

796

H-Index (Scopus)

15

Citation (Scholar)

35

H-Index (Scholar)

4

Citation (TrDizin)

1

H-Index (TrDizin)

1

Citation (Sobiad)

2

H-Index (Sobiad)

1

Citation (Sum Other)

4

Thesis Advisory

6

Open Access

36
UN Sustainable Development Goals